Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called REOLYSIN® for the treatment of solid tumors and hematological malignancies.

Biotechnology

Oncolytics Biotech

Oncolytics Biotech's headquarters in Calgary, Canada

Jared Kelly

Mary Ann Dillahunty

Allison Hagerman

Thomas C. Heineman

Kirk Look

Angela Holtham

Bernd R. Seizinger

James T. Parsons

Wayne Pisano

Deborah M. Brown

Jonathan Rigby

Product Development and Regulatory Affairs

Leadership Team

Clinical Operations

Oncolytics Biotech

Org chart

Board & advisors

Teams

Product Development and Regulatory Affairs

Leadership Team

Clinical Operations

Offices

Similar companies